Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Management System Market by Type (Hardware, Services, Software), Delivery Mode (Cloud-Based (SaaS), Licensed Enterprise (On-Premises), Web-based (On-Demand)), End-User, Deployment - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The latest market analysis report on the global Clinical Trials Management System (CTMS) market has been made available, providing critical insights into the sector's expansion and the prevailing trends shaping its future. The research, a thorough document enriched with valuable data, indicates that the market size was valued at USD 1.26 billion in 2023 and is anticipated to achieve an exponential compound annual growth rate (CAGR) of 16.65%, reaching a formidable USD 3.71 billion by the year 2030.
An intelligent exploration of the CTMS market is presented in the report, which introduces the FPNV Positioning Matrix as a key tool in the analysis of vendor performance. This matrix plays an essential role in enabling business leaders to choose the solutions that best meet their organizational needs, segmenting vendors into four categories: Forefront, Pathfinder, Niche, or Vital.
The Market Share Analysis further contributes by offering a granular look at the competitive landscape, detailing vendors’ market presence, customer base, and other significant indicators, that narrate the narrative of market dominance and competition over the specified period.
Key Company Profiles section of the report is instrumental in showcasing the market's movers and shakers. Eminent players such as Advarra Technology Solutions, Calyx Clinical Research Solutions, and many others receive accolades for their product innovations and business strategy enhancements.
Detailing the segmentation across various dimensions, the report covers the CTMS market by type, including hardware, services, and software. It puts a lens on delivery modes like cloud-based (SaaS), licensed enterprise (on-premises), web-based (on-demand), and outlines the market spectrum accross end-users consisting of clinical research organizations, healthcare providers, and pharmaceutical & biotechnology companies. Additionally, it inspects the regional market dynamics over the Americas, Asia-Pacific, and Europe, Middle East & Africa.
Market Penetration and Market Development sections inform on the spread and advancement of CTMS across various markets, while Market Diversification spotlights new products and geographic areas ripe for investment. A thorough Competitive Assessment & Intelligence analysis provides a benchmark for assessing the strategic positioning of key market players. In the domain of Product Development & Innovation, the report reveals forward-looking perspectives on emerging technology trends and R&D movements.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 195 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $1.47 Billion |
| Forecasted Market Value (USD) by 2030 | $3.71 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
Companies Mentioned
- Advarra Technology Solutions
- Calyx Clinical Research Solutions
- Clario
- Datatrak Int.
- DataTrak International, Inc.
- DSG, Inc.
- DZS Clinical Services, Inc.
- International Business Machines Corporation
- IQVIA Holdings, Inc.
- MasterControl, Inc.
- Medidata Solutions, Inc. by Dassault Systèmes
- MedNet Solutions, Inc.
- Oracle Corporation
- PAREXEL International Corporation
- RealTime Software Solutions, LLC
- Veeva Systems Inc.
For more information about this report visit https://www.researchandmarkets.com/r/4kpihr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
